Shupack JL - Search Results

1

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.

Tseng S, Pak G, Washenik K, Pomeranz MK, Shupack JL. Tseng S, et al. Among authors: shupack jl. J Am Acad Dermatol. 1996 Dec;35(6):969-79. doi: 10.1016/s0190-9622(96)90122-x. J Am Acad Dermatol. 1996. PMID: 8959957 Free article. Review.

2

Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.

Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL. Kitchin JE, et al. Among authors: shupack jl. J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):445-9. doi: 10.1016/s0190-9622(97)70147-6. J Am Acad Dermatol. 1997. PMID: 9308561 Free article. Review.

3

Efficacy of topical sensitizers in the treatment of alopecia areata.

Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Rokhsar CK, et al. Among authors: shupack jl. J Am Acad Dermatol. 1998 Nov;39(5 Pt 1):751-61. doi: 10.1016/s0190-9622(98)70048-9. J Am Acad Dermatol. 1998. PMID: 9810892 Free article. Review.

4

Necrobiosis lipoidica diabeticorum treated with chloroquine.

Nguyen K, Washenik K, Shupack J. Nguyen K, et al. J Am Acad Dermatol. 2002 Feb;46(2 Suppl Case Reports):S34-6. doi: 10.1067/mjd.2002.104969. J Am Acad Dermatol. 2002. PMID: 11807467 Review.

5

Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.

Strober BE, Siu K, Alexis AF, Kim G, Washenik K, Sinha A, Shupack JL. Strober BE, et al. Among authors: shupack jl. J Am Acad Dermatol. 2005 Jun;52(6):1082-4. doi: 10.1016/j.jaad.2005.03.039. J Am Acad Dermatol. 2005. PMID: 15928633 Clinical Trial.

6

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.

Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE. Carucci JA, et al. Arch Dermatol. 1998 Jul;134(7):785-6. doi: 10.1001/archderm.134.7.785. Arch Dermatol. 1998. PMID: 9681340 No abstract available.

7

A role for leukotriene antagonists in atopic dermatitis?

Chari S, Clark-Loeser L, Shupack J, Washenik K. Chari S, et al. Am J Clin Dermatol. 2001;2(1):1-6. doi: 10.2165/00128071-200102010-00001. Am J Clin Dermatol. 2001. PMID: 11702615 Review.

8

A portable pulsed electromagnetic field (PEMF) device to enhance healing of recalcitrant venous ulcers: a double-blind, placebo-controlled clinical trial.

Stiller MJ, Pak GH, Shupack JL, Thaler S, Kenny C, Jondreau L. Stiller MJ, et al. Among authors: shupack jl. Br J Dermatol. 1992 Aug;127(2):147-54. doi: 10.1111/j.1365-2133.1992.tb08047.x. Br J Dermatol. 1992. PMID: 1390143 Clinical Trial.

9

Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.

Stiller MJ, Pak GH, Kenny C, Jondreau L, Davis I, Wachsman S, Shupack JL. Stiller MJ, et al. Among authors: shupack jl. J Am Acad Dermatol. 1992 Sep;27(3):434-8. doi: 10.1016/0190-9622(92)70213-y. J Am Acad Dermatol. 1992. PMID: 1401280 Free article. Clinical Trial.

10

New York University therapeutic roundtable: a panel of experts answer questions on the treatment of challenging cases.

Shupack JL, Kanof N, Stolman LP, Vogel L, Whitlow M, Cohen DE, Washenik K, Lee MP, Stiller MJ. Shupack JL, et al. Cutis. 1994 Jul;54(1):29-33. Cutis. 1994. PMID: 7924446 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters